Asian Science Citation Index is committed to provide an authoritative, trusted and significant information by the
coverage of the most important and influential journals
to meet the needs of the global scientific community.
The Reynolds Risk Score best-fitting model (RRS) estimates 10-year coronary heart disease (CHD) risk by incorporating an expanded number of risk markers, including A1C, systolic blood pressure, C-reactive protein (hsCRP), apolipoproteins, and the interaction of lipoprotein(a) and ApoB. Treatment of type 2 diabetes (T2DM) with the GLP-1 receptor agonist exenatide has been reported to improve A1C, body weight, blood pressure, and lipid profiles; however, evidence regarding the impact of exenatide on other apolipoproteins is limited.
